Parliament vote clears the way for EU pharmacovigilance fees
This article was originally published in SRA
Executive Summary
The European Parliament has voted through the EU regulation on fees payable by drug companies to the European Medicines Agency for conducting pharmacovigilance activities for medicines. A total of 544 MEPs voted in favor of the legislation, with 17 against and 11 abstentions1.